logo

For the Inventor, By the Inventor

Birchwood, MN, United States of America

Hugh McTavish

This inventor holds 26 USPTO granted patents and 6 published patent applications and 4 EPO patents, primarily in Biotechnology Innovations. Top assignees: Igf Oncology, LLC, Square, Inc., Novus Energy LLC. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hugh McTavish. Retrieved from https://idiyas.com/inventor/hugh-mctavish

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 76.9

 

Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 94(Granted Patents)


Location History:

  • Saint Paul, MN (US) (2002)
  • Birchwood, MN (US) (2004 - 2015)
  • Pine Springs, MN (US) (2015 - 2024)

Company Filing History:

goldMedal10 out of 11 
 
Igf Oncology, LLC
 patents
silverMedal3 out of 748 
 
Square, Inc.
 patents
bronzeMedal2 out of 3 
 
Novus Energy LLC
 patents
4. 2 out of 2,373 
 
Regents of the University of Minnesota
 patents
5. 1 out of 100 
 
Bioventures, LLC
 patents
6. 1 out of 1 
 
Squarex Pharmaceutical Corporation
 patent
7. 1 out of 1 
 
Squarox, LLC
 patent
8. 1 out of 1 
 
Strokemaster Backboard, LLC
 patent
9. 1 out of 850 
 
University of Arkansas
 patents
10. 5 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Delayed-Type Hypersensitivity
Fusion Proteins
Insulin-Like Growth Factor
Epidermal Growth Factor
Cancer Treatment
Viral Infections
Fungal Infections
Bio-Recycling
Ethanol Production
Microbial Remediation
Radionuclides
Toxins
26 patents (USPTO):Explore Patents
1. 12128098 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2024-10-29),
2. 11957783 - Topical immunosensitizers to treat viral and fungal infections (2024-04-16),
3. 11324834 - Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome (2022-05-10),
4. 10967049 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2021-04-06),
5. 10940197 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2021-03-09),
6. 10744084 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2020-08-18),
7. 10391147 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2019-08-27),
8. 10245314 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2019-04-02),
9. 9801923 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2017-10-31),
10. 9675671 - Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof (2017-06-13),
11. 9205065 - Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection (2015-12-08),
12. 9011880 - Compounds and methods for treating cancer (2015-04-21),
13. 8920777 - Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer (2014-12-30),
14. 8501906 - Compounds and methods for treating cancer (2013-08-06),
15. 8017102 - Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer (2011-09-13),

Title: The Inventor Profile of Hugh McTavish

Introduction: Hugh McTavish is a renowned inventor based in Birchwood, Minnesota. With a passion for innovation and problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Hugh McTavish holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices. His recent patents focus on enhancing efficiency and sustainability in everyday processes.

Career Highlights: Throughout his career, Hugh McTavish has been recognized for his groundbreaking inventions that have improved the quality of life for many. His dedication to creating solutions for complex challenges has led to numerous successful ventures.

Collaborations: Hugh McTavish has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work in multidisciplinary teams has resulted in innovative products that have made a positive impact on society.

Conclusion: In conclusion, Hugh McTavish's innovative mindset and commitment to pushing the boundaries of technology have established him as a prominent figure in the world of inventions. His work continues to inspire future generations of inventors to think creatively and strive for excellence in their pursuits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…